Zhang, F., Shi, Z., Shi, Q., Zhu, Y., Zhao, W. L., Wang, L. (2025). A prospective, multicenter, randomized, controlled clinical trial comparing polatuzumab vedotin, zanubrutinib, lenalidomide, and rituximab (Pola-ZR2) versus zanubrutinib, lenalidomide, and rituximab (ZR2) in the treatment of previously untreated, elderly patients with diffuse large B-cell lymphoma (NCT06522555). Blood. https://doi.org/10.1182/blood-2025-3696